E-LIB Suche - Ergebnisse für: Cherney, David Z.I.

1

Management of Type 2 Diabetic Kidney Disease in 2022: A Nar..:

Cherney, David Z. I ; Bell, Alan ; Girard, Louis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884958/. , 2023

2

Effects of Tirzepatide Versus Insulin Glargine on Cystatin ..:

Heerspink, Hiddo J.L ; Sattar, Naveed ; Pavo, Imre...
https://research.rug.nl/en/publications/38399e29-1810-4062-a4b2-ede015da9820. , 2023

Link: https://hdl.handle.net/1..

3

The Effects of Sotagliflozin in Type 1 Diabetes on Clinical..:

Sridhar, Vikas S ; Heerspink, Hiddo J.L ; Davies, Michael J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300514/. , 2023

Link: http://www.ncbi.nlm.nih...

4

Effects of Ertugliflozin on Kidney Outcomes in Patients Wit..:

Cherney, David Z.I ; Cosentino, Francesco ; McGuire, Darren K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105061/. , 2023

Link: http://www.ncbi.nlm.nih...

5

The Effects of Sotagliflozin in Type 1 Diabetes on Clinical..:

Sridhar, Vikas S ; Heerspink, Hiddo J.L ; Davies, Michael J...
https://research.rug.nl/en/publications/d391bfee-b18f-4a8f-9e3d-2a743533401a. , 2023

Link: https://hdl.handle.net/1..

6

Ertugliflozin and hospitalization for heart failure across ..:

Pandey, Ambarish ; Kolkailah, Ahmed A ; Cosentino, Francesco...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10733716/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Insights into the Regulation of GFR by the Keap1-Nrf2 Pathw..:

Kidokoro, Kengo ; Kadoya, Hiroyuki ; Cherney, David Z. I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615375/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Safety, tolerability, pharmacodynamics and pharmacokinetics..:

Cherney, David Z.I ; de Zeeuw, Dick ; Heerspink, Hiddo J.L...
https://research.rug.nl/en/publications/ffbef02a-f0e4-48ac-ae9a-82a1558d5dab. , 2023

Link: https://hdl.handle.net/1..

9

Rationale and design of a randomised phase III registration..:

Heerspink, Hiddo J.L ; Birkenfeld, Andreas L ; Cherney, David Z.I...
https://research.rug.nl/en/publications/e11de8c8-c6ce-4bb7-9d74-1542924c85fb. , 2023

Link: https://hdl.handle.net/1..

10

Rationale and design of a randomised phase III registration..:

Heerspink, Hiddo J. L ; Birkenfeld, Andreas L ; Cherney, David Z. I...
10.1016/j.diabres.2023.110908. , 2023

Link: http://hdl.handle.net/10..

11

Erratum. Association Between Obesity and Chronic Kidney Dis..:

Nguyen, Anthony ; Khafagy, Rana ; Gao, Yiding...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382645/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Effects of Tirzepatide Versus Insulin Glargine on Cystatin ..:

Heerspink, Hiddo J.L ; Sattar, Naveed ; Pavo, Imre...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369133/. , 2023

Link: http://www.ncbi.nlm.nih...

13

Effects of empagliflozin on fluid overload, weight and bloo..:

Mayne, Kaitlin J ; Staplin, Natalie ; Keane, David F...
https://eprints.gla.ac.uk/308922/1/308922.pdf. , 2023

Link: https://eprints.gla.ac.u..

14

Effect of dapagliflozin on kidney and cardiovascular outcom..:

Waijer, Simke W ; Vart, Priya ; Cherney, David Z.I...
https://research.rug.nl/en/publications/204e04ba-5ff9-48a7-b88e-aeb34bf7e319. , 2022

Link: https://hdl.handle.net/1..

15

Effects of dapagliflozin on volume status and systemic haem..:

Sen, Taha ; Scholtes, Rosalie ; Greasley, Peter J...
https://research.rug.nl/en/publications/8e398cd9-4073-40ac-b29a-8f0b19592d95. , 2022

Link: https://hdl.handle.net/1..